HPC Biosciences Limited reported earnings results for the half year ended September 30, 2022. For the half year, the company reported sales was INR 1.03 million compared to INR 4.08 million a year ago. Revenue was INR 3.34 million compared to INR 4.54 million a year ago.

Net loss was INR 0.488 million compared to net income of INR 0.627 million a year ago.